awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34050239-C64FBEDE-4607-434C-A172-C01E1539939E
Q34050239-C64FBEDE-4607-434C-A172-C01E1539939E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34050239-C64FBEDE-4607-434C-A172-C01E1539939E
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.
P433
Q34050239-C64FBEDE-4607-434C-A172-C01E1539939E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34050239-C64FBEDE-4607-434C-A172-C01E1539939E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
acf87a891087ad61df327a8c336b54239b0060d6
P433
9780
http://www.w3.org/2001/XMLSchema#string